SABUS STEVE M (SVP & Chief Commercial Officer) reported 1 transaction at TURNING POINT THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/17/2022ACC: 0001209191-22-046268
Officer· SVP & Chief Commercial Officer
Since May 2022
-201.67K
Net shares
Net seller
$2.79M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
201.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−36.67K
Price / share
$76.00
Trade value
$2.79M
% of position
New position
8/17/2022
36.67K→0.00
Total
Net shares
−36.67K
Net value
-$2.79M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2022 | D · Disposition | −36.67K | $76.00 | $2.79M | New position | 36.67K | 0.00 |
| Total | −36.67K | -$2.79M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
165K shares
Shares
−165K
Strike price
35.37
Held after
0.00
Exercisable
—
8/17/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock165K shares | 8/17/2022 | D · Disposition | −165K | 35.37 | — | 0.00 |